SEASTAR MEDICAL HOLDING CORP (ICU) Forecast, Price Target & Analyst Ratings

NASDAQ:ICU • US81256L3024

Current stock price

2.21 USD
-0.02 (-0.9%)
At close:
2.2601 USD
+0.05 (+2.27%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SEASTAR MEDICAL HOLDING CORP (ICU).

Forecast Snapshot

Consensus Price Target

Price Target
$9.18
+ 315.38% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 25, 2026
Period
Q4 / 2025
EPS Estimate
-$1.07
Revenue Estimate
376.225K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.18
Upside
+ 315.38%
From current price of $2.21 to mean target of $9.18, Based on 5 analyst forecasts
Low
$6.06
Median
$9.18
High
$12.60

Price Target Revisions

1 Month
-18.18%
3 Months
800.00%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for ICU. The average price target is 9.18 USD. This implies a price increase of 315.38% is expected in the next year compared to the current price of 2.21.
The average price target has been revised upward by 800% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ICU Current Analyst RatingICU Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ICU Historical Analyst RatingsICU Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
ICU was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ICU.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed ICU. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-04-20Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 25, 2026
Period
Q4 / 2025
EPS Estimate
-$1.07
Revenue Estimate
376.225K
Revenue Q2Q
461.53%
EPS Q2Q
88.10%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
52.04%
EPS (1 Month)
1.85%
EPS (3 Months)
-863.64%

Next Earnings Summary

ICU is expected to report earnings on 3/25/2026. The consensus EPS estimate for the next earnings is -1.07 USD and the consensus revenue estimate is 376.23K USD.
The next earnings revenue estimate has been revised upward by 52.04% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ICU revenue by date.ICU revenue by date.
135K1.544M
1,043.70%		2.393M
54.99%		3.337M
39.45%
EBITDA
YoY % growth
ICU ebitda by date.ICU ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ICU ebit by date.ICU ebit by date.
-11.61M
-160.90%		-14.21M
-22.39%		-17.842M
-25.56%		-12.514M
29.86%		-15.312M
-22.35%		-15.122M
1.24%
Operating Margin
ICU operating margin by date.ICU operating margin by date.
N/AN/A-13,216.30%-810.52%-639.85%-453.17%
EPS
YoY % growth
ICU eps by date.ICU eps by date.
N/AN/A-77.80
73.21%		-6.46
91.69%		-3.36
48.05%		-2.55
24.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.07
88.10%		-1.07
75.67%		-1.12
37.72%		-1.08
16.87%		-1.13
-5.66%
Revenue
Q2Q % growth		376.225K
461.53%		378.75K
29.27%		477.73K
41.34%		354.51K
93.72%		544.39K
44.70%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-3.597M
24.54%		-4.159M
-8.82%		-4.42M
-151.69%		-4.997M
-39.63%		-5.331M
-48.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 1M 2M 3M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.30%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
147.47%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SEASTAR MEDICAL HOLDING CORP / ICU Forecast FAQ

What do analysts expect the price target to be for SEASTAR MEDICAL HOLDING CORP (ICU)?

5 analysts have analysed ICU and the average price target is 9.18 USD. This implies a price increase of 315.38% is expected in the next year compared to the current price of 2.21.

What is the next earnings date for ICU stock?

SEASTAR MEDICAL HOLDING CORP (ICU) will report earnings on 2026-03-25, after the market close.

What are the consensus estimates for ICU stock next earnings?

The consensus EPS estimate for the next earnings of SEASTAR MEDICAL HOLDING CORP (ICU) is -1.07 USD and the consensus revenue estimate is 376.23K USD.

What is the expected long term growth rate for SEASTAR MEDICAL HOLDING CORP (ICU)?

The expected long term growth rate for SEASTAR MEDICAL HOLDING CORP (ICU) is 147.47%.